News

NIH launched a new federal challenge to seek new innovations in the diagnosis of endometriosis to broaden accessibility and improve women’s health. Submissions are due October 11, 2024.

NICHD is co-hosting several workshops and virtual meetings on women’s health topics in summer 2024. Please consider registering to participate in discussions and to help shape future research and care.

Within NIH, NICHD leads research focused on women’s health “below the belt.” This includes addressing a spectrum of gynecological and reproductive health issues, from endometriosis to pelvic floor disorders.

An NIH-funded study suggests that fenoprofen may be a potential therapeutic for endometriosis, a disease that affects approximately 1 in 10 U.S. women. The researchers used a computer algorithm to evaluate nearly 1,300 existing drugs and tested their top candidate, fenoprofen, in a rodent model of the disease.

Around 200 million people worldwide live with endometriosis, a common gynecological disease with symptoms that include pelvic pain, fatigue, and infertility. NICHD recently hosted a discussion about advances and new directions in endometriosis research, and the imperative of raising awareness and education about the disease.

In 2023, NICHD continued its commitment to research to understand human development, improve reproductive health, promote women’s health, enhance the lives of children and adolescents, and optimize abilities for all. Highlights include steps toward reducing the global burden of maternal sepsis and establishing a standard treatment for opioid-exposed newborns.

As we ring in 2024, we’d like to take a brief look back on our accomplishments during 2023. These activities illustrate the institute’s continued commitment to research and training in its mission areas.

Endometriosis affects an estimated 10% of women, can cause severe pain and infertility, and typically has long delays in diagnosis. NICHD is accelerating efforts to definitively diagnose, prevent, and treat this chronic disease.

The gynecologic condition endometriosis has several differences in gene expression in the uterine lining, according to a comprehensive analysis of nearly 1,000 tissue samples by researchers funded in part by the National Institutes of Health. The differences stem from variations in DNA methylation—the binding of compounds known as methyl groups to DNA.

Small businesses play a critical role in driving scientific progress by helping to move innovations out of labs and into the public marketplace. NICHD grants to small businesses have supported development of products ranging from the first FDA-approved endometriosis treatment to at-home rehabilitation devices.

Oleuropein, a compound found in olive oil and olive leaves, may have the potential to treat endometriosis with fewer side effects than current treatments, suggests a study of mice and human tissue cultures funded by the National Institutes of Health.

Read about NICHD’s research findings and activities from 2022.

Women with endometriosis may have a higher risk for stroke, suggests a study funded by the National Institutes of Health. The analysis of more than 110,000 women found that compared to women without the condition, women who had been diagnosed with endometriosis had a 34% higher risk for stroke. The study authors concluded that physicians should consider counseling patients with endometriosis about their risk for stroke and other cardiovascular conditions.

Technique adapted from cancer treatment shows promise in mouse study.

NICHD-funded small business programs have led to innovations for patients, healthcare providers, researchers, and more. Learn about these success stories.

As we usher in November and Thanksgiving, it’s a fitting time to reflect on NICHD’s commitment to research on nutrition.

Read about NICHD’s research findings and activities from 2020.

NICHD has supported gynecologic and reproductive health research for decades. Learn more about its leading role in menstruation research.

DNA from uterine cells of women with endometriosis has different chemical modifications, compared to the DNA of women who do not have the condition, according to researchers funded by the National Institutes of Health. The changes involve DNA methylation—the binding of compounds known as methyl groups to DNA—which can alter gene activity.

Research on the causes of and effective treatments for endometriosis is a high priority for NICHD. Our grantees share their findings and ongoing research.